Dr. Jian Chen, People's Republic of China
In vivo delivery of CRISPR-Cas9 via lipid nanoparticles enhances hepatocyte transplantation by inducing host hepatocyte senescence
Dr. Shoki Suzuki MD, PhD, Japan
Mocravimod, a novel immunosuppressant, not only suppresses immune rejection but also promotes engraftment of intraportally transplanted islets by its anti-inflammatory and anti-coagulant effects